We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$298B
AUM Growth
+$23.2B
Cap. Flow
+$26.9B
Cap. Flow %
9.01%
Top 10 Hldgs %
23.64%
Holding
11,380
New
1,223
Increased
4,885
Reduced
3,876
Closed
1,294

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.58B
2
NFLX icon
Netflix
NFLX
+$496M
3
META icon
Meta Platforms (Facebook)
META
+$275M
4
BABA icon
Alibaba
BABA
+$215M
5
UNH icon
UnitedHealth
UNH
+$189M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.18%
2 Technology 2.09%
3 Communication Services 1.44%
4 Financials 1.21%
5 Healthcare 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRQ
9876
DELISTED
Turquoise Hill Resources Ltd
TRQ
$26K ﹤0.01%
5,513
-6,762
-55% -$40.7K
ZN
9877
CALL
DELISTED
Zion Oil & Gas, Inc.
ZN
$26K ﹤0.01%
100,900
+7,000
+7% +$2.26K
FNJN
9878
CALL
DELISTED
Finjan Holdings, Inc.
FNJN
$26K ﹤0.01%
+13,000
New +$26.8K
CDTX
9879
DELISTED
Cidara Therapeutics
CDTX
$25K ﹤0.01%
+638
New +$21.4K
EVOK
9880
DELISTED
Evoke Pharma
EVOK
$25K ﹤0.01%
205
-36
-15% -$4.83K
OTLK icon
9881
Outlook Therapeutics
OTLK
$155M
$25K ﹤0.01%
+828
New +$31.9K
AAU
9882
DELISTED
Almaden Minerals Ltd
AAU
$25K ﹤0.01%
+38,518
New +$27.5K
BKEP
9883
DELISTED
Blueknight Energy Partners L.P.
BKEP
$25K ﹤0.01%
+22,756
New +$28.7K
NVTR
9884
DELISTED
Nuvectra Corporation Common Stock
NVTR
$25K ﹤0.01%
+18,124
New +$35.5K
CLDX icon
9885
CALL
Celldex Therapeutics
CLDX
$3.24B
$24K ﹤0.01%
11,200
-18,900
-63% -$43.7K
INO icon
9886
CALL
Inovio Pharmaceuticals
INO
$133M
$24K ﹤0.01%
967
-241
-20% -$7.33K
AMPE
9887
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$24K ﹤0.01%
162
-493
-75% -$65.7K
XELA
9888
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$24K ﹤0.01%
2
+1
+100% +$20.6K
BDRX
9889
Biodexa Pharmaceuticals
BDRX
$1.21M
0
EYPT icon
9890
CALL
EyePoint Inc
EYPT
$431M
$23K ﹤0.01%
+1,260
New +$19.5K
JILL icon
9891
J. Jill
JILL
$295M
$23K ﹤0.01%
2,424
-7,057
-74% -$71.7K
VUZI icon
9892
CALL
Vuzix
VUZI
$231M
$23K ﹤0.01%
10,100
-98,000
-91% -$226K
TRVN
9893
DELISTED
Trevena, Inc.
TRVN
$23K ﹤0.01%
38
-643
-94% -$377K
INFI
9894
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$23K ﹤0.01%
22,400
+2,200
+11% +$3K
TDW.WS.B
9895
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$23K ﹤0.01%
19,181
+4,272
+29% +$8.74K
NYMX
9896
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$23K ﹤0.01%
12,500
-5,000
-29% -$8.74K
IDXG
9897
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$23K ﹤0.01%
+2,920
New +$22.8K
IGC icon
9898
PUT
IGC Pharma
IGC
$31.5M
$22K ﹤0.01%
22,400
+8,200
+58% +$9.87K
VBIV
9899
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$22K ﹤0.01%
1,538
-119
-7% -$2.49K
USWS
9900
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$22K ﹤0.01%
481
-2,110
-81% -$139K

Similar funds

Jeff Yass's Q3 2019 Portfolio in Review

As of Q3 2019, Jeff Yass held 11,380 positions worth $298B, up 8.4% from $275B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass deployed $26.9B of net new capital in Q3 2019, opening 1,223 new positions and adding to 4,885 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 1.8% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $926M trimmed.

  • Jeff Yass's largest Q3 2019 buy was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
  • Jeff Yass added most to Amazon in Q3 2019, an estimated $1.58B increase.
  • Jeff Yass's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $926M.
  • Jeff Yass fully exited Tableau Software, Inc. in Q3 2019, selling an estimated $179M.
  • Jeff Yass's ten largest holdings make up 24% of its $298B portfolio in Q3 2019.
  • Jeff Yass opened 1,223 new positions and closed 1,294 in Q3 2019.
  • Jeff Yass's portfolio value rose 8.4% quarter-over-quarter to $298B.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.